Employees: 00 (2023.0)Legal category: Société à responsabilité limitée (sans autre indication)Size: PMECreation date: 2012-09-10 (13 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: BORDEAUX (33000), Gironde
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE H. LASSERE-DUPOUY : revenue, balance sheet and financial ratios
PHARMACIE H. LASSERE-DUPOUY is a French company
founded 13 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in BORDEAUX (33000),
this company of category PME
shows in 2022 a revenue of 2.3 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE H. LASSERE-DUPOUY (SIREN 788417368)
Indicator
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
N/C
2 289 974 €
N/C
N/C
N/C
N/C
N/C
N/C
Net income
1 044 323 €
235 353 €
256 109 €
258 864 €
237 732 €
245 813 €
273 569 €
248 896 €
EBITDA
N/C
268 932 €
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
10.3%
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2023, PHARMACIE H. LASSERE-DUPOUY generates positive net income of 1.0 M€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2023: 249 k€ -> 1.0 M€.
Net income (2023)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
1 044 323 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 91%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 49%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2023)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
90.977%
Financial autonomy (2023)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
48.907%
Asset age ratio (2023)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE H. LASSERE-DUPOUY
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
Debt ratio
0.0
369.01
405.188
408.511
362.624
352.517
374.092
90.977
Financial autonomy
18.142
19.199
18.151
17.849
18.609
19.383
18.474
48.907
Repayment capacity
None
None
None
None
None
None
3.748
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
11.697%
None%
Sector positioning
Debt ratio
90.982023
2021
2022
2023
Q1: 20.09
Med: 66.92
Q3: 169.24
Average-19 pts over 3 years
In 2023, the debt ratio of PHARMACIE H. LASSERE-DUPOUY (90.98) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
48.91%2023
2021
2022
2023
Q1: 28.72%
Med: 48.51%
Q3: 68.17%
Good+26 pts over 3 years
In 2023, the financial autonomy of PHARMACIE H. LASSERE-DUPOUY (48.9%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Repayment capacity
3.75 years2022
2022
Q1: 1.29 years
Med: 3.55 years
Q3: 6.63 years
Average
In 2022, the repayment capacity of PHARMACIE H. LASSERE-DUPOUY (3.75) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 1514.32. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2023)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
1514.323
Liquidity indicators evolution PHARMACIE H. LASSERE-DUPOUY
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
Liquidity ratio
309.646
245.257
263.545
236.676
184.176
176.953
164.9
1514.323
Interest coverage
None
None
None
None
None
None
2.356
None
Sector positioning
Liquidity ratio
1514.322023
2021
2022
2023
Q1: 135.25
Med: 189.78
Q3: 270.35
Excellent+32 pts over 3 years
In 2023, the liquidity ratio of PHARMACIE H. LASSERE-DUPOUY (1514.32) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Interest coverage
2.36x2022
2022
Q1: 0.74x
Med: 2.5x
Q3: 5.15x
Average
In 2022, the interest coverage of PHARMACIE H. LASSERE-DUPOUY (2.4x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2023)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2023)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2023)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2023)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE H. LASSERE-DUPOUY
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
Operating WCR
0 €
0 €
0 €
0 €
0 €
0 €
201 243 €
0 €
Inventory turnover (days)
0
0
0
0
0
0
29
0
Customer payment term (days)
0
0
0
0
0
0
5
0
Supplier payment term (days)
0
0
0
0
0
0
24
0
Positioning of PHARMACIE H. LASSERE-DUPOUY in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 220 transactions of similar company sales
in 2023,
the value of PHARMACIE H. LASSERE-DUPOUY is estimated at
12 322 464 €
(range 7 493 880€ - 17 322 619€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2023
220 transactions
7493k€12322k€17322k€
12 322 464 €Range: 7 493 880€ - 17 322 619€
NAF 5 année 2023
Valuation method used
Net Income Multiple
1 044 323 €
×
11.8x
=12 322 464 €
Range: 7 493 880€ - 17 322 620€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 220 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE H. LASSERE-DUPOUY with other companies in the same sector:
Frequently asked questions about PHARMACIE H. LASSERE-DUPOUY
What is the revenue of PHARMACIE H. LASSERE-DUPOUY ?
The revenue of PHARMACIE H. LASSERE-DUPOUY in 2022 is 2.3 M€.
Is PHARMACIE H. LASSERE-DUPOUY profitable?
Yes, PHARMACIE H. LASSERE-DUPOUY generated a net profit of 1.0 M€ in 2023.
Where is the headquarters of PHARMACIE H. LASSERE-DUPOUY ?
The headquarters of PHARMACIE H. LASSERE-DUPOUY is located in BORDEAUX (33000), in the department Gironde.
Where to find the tax return of PHARMACIE H. LASSERE-DUPOUY ?
The tax return of PHARMACIE H. LASSERE-DUPOUY is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE H. LASSERE-DUPOUY operate?
PHARMACIE H. LASSERE-DUPOUY operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart